MAP1LC3A and metabolic dysfunction-associated steatotic liver disease: We first measured the protein level of LC3 and found that the ratio of LC3II/LC3I was markedly decreased in NAFLD mice, while hUC-MSC administration upregulated LC3II/LC3I ratio, indicating that autophagy was activated by hUC-MSC treatment (Fig. 5A).